~~<i id='0524765D7A'><strike id='0524765D7A'><tt id='0524765D7A'><pre id='0524765D7A'></pre></tt></strike></i>~~

00:00

00:00 00:00 LIVE

buffering

Replay

explore

fashion

author：fashion 2025-09-27 19:37:49 - browse：112

Aduhelm, a pioneering treatment for Alzheimer’s disease that collapsed under corporate mistakes and regulatory controversy, is now a cautionary tale in pharmaceutical history.

This week Biogen said it would no longer sell or study the medicine, which first won approval in 2021, ending an era for one of biotech’s storied companies and leaving the rest of the industry to piece together the lessons of a would-be blockbuster that never took off.

STAT reporters took a stab at the Aduhelm legacy — for biotech, Biogen, and Alzheimer’s research — on a recent episode of the Readout LOUD. Here’s an edited transcript of that conversation.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Anesthesiologist group: stop taking Ozempic before surgery
Next article： Doctor appointment wait times are getting worse

leisure time

focus

hotspot

leisure time

1:18AtaxidriversplasheswaterintohisfacetocooloffinadowntownstreetduringahotandsunnydayinTehran,Iran,

WSS

RaDonda Vaught case: a double standard for nurses, physicians

Mike Pence ‘not interested in trading insults’ with Trump as he tries to win New Hampshire

Charges dismissed against white woman who spat on Black woman during protests in Connecticut

Duchenne patients, backed by ‘dark money’ group, to debate drug prices

Option Care buys Amedisys in $3.6 billion home care deal

Transgender women dream of pregnancy via uterus transplants

explore

fashion

leisure time

Guidelines to prevent youth baseball injuries need more muscle

4 missing after record

Hepatitis C has a cure — but many Americans still lack access to it

Burning questions about Delta and the next phase of the Covid pandemic

Trump demands the U.S. pay no more for drugs than other countries … again

Malaysia cuts short music fest after British band slams anti

Tori Bowie and the unacceptable rates of Black maternal death

Sophia Smith scores twice for US in in 3

Supreme Court strikes down use of affirmative action

Novartis develops a rapidly manufactured CAR

leisure time

Mike Pence ‘not interested in trading insults’ with Trump as he tries to win New Hampshire

RaDonda Vaught case: a double standard for nurses, physicians

A new study asks: Are we harming blood donors by taking blood?

Hundreds of thousands march in Israel. Former security chiefs beg Netanyahu to halt legal overhaul

Clinic falsely told dozens they had Alzheimer's, suits say

Weekend shootings leave at least 6 dead, 20 others wounded in Chicago

focus

focus

hotspot

leisure time